Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

81103-11-9

Clarithromycin

81103-11-9
36507-30-9

Carbamazepine-10,11-epoxide

36507-30-9
23593-75-1

Clotrimazole

23593-75-1
6055-19-2

Cyclophosphamide monohydrate

6055-19-2
59729-32-7

Citalopram HBr

59729-32-7
58955-93-4

Carbamazepine-10,11-trans-diol

58955-93-4
5278-95-5

Chlorodibromoacetique acide

5278-95-5
331-39-5

Caffeic Acid

331-39-5
86393-32-0

Ciprofloxacin HCl hydrate

86393-32-0
637-07-0

Clofibrate

637-07-0
86483-48-9

Ciprofloxacin HCl

86483-48-9
64-72-2

Chlortetracycline HCl

64-72-2
541-15-1

Carnitine-L

541-15-1
52-90-4

Cysteine-L

52-90-4
72558-82-8

Ceftazidime

72558-82-8
63527-52-6

Cefotaxime acid

63527-52-6
104376-79-6

Ceftriaxone sodium

104376-79-6
122-18-9

Cetalkonium chloride

122-18-9
1119-97-7

Cetrimide

1119-97-7
57-09-0

Cetrimonium bromide

57-09-0